Summary: A study uncovered a novel neuroimmune mechanism explaining how rapid-acting antidepressants, including ketamine and psychedelics, alleviate treatment-resistant depression. Despite acting on different initial neural receptors, these distinct fast-acting therapeutics…
- Monday, August 3, 2026
